Company Search:
Advanced Search
Sponsored Links
Dongsung Pharmaceutical Company Limited Company Snapshot
Dongsung Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dongsung Pharmaceutical Company Limited with three other companies in this sector in KOREA (SOUTH) : Humedix Co Ltd (2020 sales of 98.48 billion Korean Won [US$84.30 million] of which 78% was Finished goods), PharmGen Science Inc (96.61 billion Korean Won [US$82.70 million] of which 100% was Pharmaceutical Segment), and Hanall Biopharma Co Ltd (88.60 billion Korean Won [US$75.84 million] of which 100% was Medical production and sales).

Sales Analysis. During the second quarter of 2021, sales at Dongsung Pharmaceutical Company Limited totalled 22.96 billion Korean Won . This is a drop of 12.3% from the 26.19 billion Korean Won in sales at the company during the second quarter in 2020. During the first two quarters of 2021, sales totalled 45.27 billion Korean Won , which is 7.4% lower than through the first two quarters of 2020. Dongsung Pharmaceutical Company Limited reported sales of 87.80 billion Korean Won (US$75.16 million) for the year ending December of 2020. This represents a very small increase of 1.5% versus 2019, when the company's sales were 86.54 billion Korean Won . Despite this increase, sales are still below the level achieved in 2018, when Dongsung Pharmaceutical Company Limited reported sales of 91.91 billion Korean Won . Sales of Cosmetics/toilet Preparation Segment saw an increase that was more than double the company's growth rate: sales were up 19.1% in 2020, from 6.95 billion Korean Won to 8.28 billion Korean Won . Not all segments of Dongsung Pharmaceutical Company Limited experienced an increase in sales in 2020: sales of Pharmaceutical Segment fell 0.1% to 79.52 billion Korean Won .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dongsung Pharmaceutical Company Limited
  Stock Performance Chart for Dongsung Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 9,140.00
(Figures in Korean Won )
1 Week -3.8%   13 Weeks -12.1%  
4 Weeks -9.5%   52 Weeks -21.2%  
Dongsung Pharmaceutical Company Limited Key Data:
  Ticker: 002210 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 87,799,927,095
(Year Ending Jan 2021).
Employees: 336
  Currency: Korean Won Market Cap: 214,223,521,080
  Fiscal Yr Ends: December Shares Outstanding: 23,438,022
  Share Type: Common Closely Held Shares: 5,537,803
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.